In conclusion, the meta-analysis demonstrated that PTEN could be an early tumorigenesis marker for breast cancer, whether PTEN methylation with negative protein expression (not only mRNA expression) was probably associated with poor survival status needs more clinical cohort studies to confirm. The gene discussed is PTEN; the disease is breast cancer.